Task: Answer the multiple-choice question.
Question: Which drug exhibits a -29.334% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) C/C(=N/NC(=O)c1cccs1)c1cccc(N)c1
(b) CCOc1ccc(C(=O)NC2CCN(CC(=O)NCc3ccccc3)CC2)cc1
Answer: b. CCOc1ccc(C(=O)NC2CCN(CC(=O)NCc3ccccc3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(C(=O)NC2CCN(CC(=O)NCc3ccccc3)CC2)cc1
CCOc1ccc(C(=O)NC2CCN(CC(=O)NCc3ccccc3)CC2)cc1
N-[1-[2-(benzylamino)-2-oxoethyl]piperidin-4-yl]-4-ethoxybenzamide